我国首个核医疗示范基地启用，行业迎政策红利+技术突破双重催化

Group 1 - The core viewpoint of the article highlights the inauguration of China's first nuclear medical demonstration base at the Suzhou University Affiliated Second Hospital, which integrates nuclear technology for precise diagnosis and treatment, clinical trials, medical innovation, and training [1] - The nuclear medical industry in China is expected to experience accelerated growth due to policy benefits and technological breakthroughs, particularly in the areas of radionuclide preparation, radiopharmaceutical development, and nuclear medical equipment [1] - The Chinese nuclear medical market is projected to maintain rapid growth from 2025 to 2030, with an expected annual output value reaching approximately 600 billion yuan by the end of the 14th Five-Year Plan [1] Group 2 - Companies such as Jingye Intelligent and CGN Technology are mentioned in relation to the nuclear medical sector [2]